EU STRUCTURAL FUNDS 2014 - 2020
European Regional Development Fund (ERDF)
Operational Programme Growth and Employment
1.1.1 Specific Aid Objective To increase the research and innovative capacity of scientific institutions of Latvia and the ability to attract external financing, investing in human resources and infrastructure
First selection round projects
1.1.1.1/16/A/044
Assessment of magnitude and importance of vectorborne Babesiosis in Latvia: epidemiological and diagnostic approach
1.1.1.1/16/A/054
Diagnostic and immunoprotective potential of influenza virus hemagglutinin stalk peptide: generation of novel vaccine prototypes
1.1.1.1/16/A/055
Development of orphan G-protein coupled receptor peptidic ligand identification system
1.1.1.1/16/A/066
Molecular markers of pituitary tumor development, progression and therapy response
1.1.1.1/16/A/101
The impact of burial environmental microbiome on biomolecular archeology and the ancient tuberculosis research
1.1.1.1/16/A/104
Obtaining and characterization of virus-like particles of novel RNA phages
1.1.1.1/16/A/107
Development of new antimicrobial agents targeting Gram-positive bacterial sortase A
1.1.1.1/16/A/211
Molecular design of new luminescent compounds for diagnostic purposes
Second selection round projects
1.1.1.1/18/A/026
1.1.1.1/18/A/099
1.1.1.1/18/A/084
Clinical utility of extracellular vesicle-enclosed human and microbial transcriptomes
1.1.1.1/18/A/089
RNA molecular determinants in development of pituitary adenoma
1.1.1.1/18/A/092
Role of miRNAs in the host-gut microbiome communication during metformin treatment in the context of metabolic disorders
1.1.1.1/18/A/096
The determination of rare inherited diseases' causative mechanisms using whole genome sequencing approach
1.1.1.1/18/A/097
Functional and genetic research of rare unidentitied neuromuscular disorders
Third selection round project
1.1.1.1/19/A/036
Interaction and dynamics of intestinal IgA and gut microbiome profile during antidiabetic therapy
Fourth selection round projects
1.1.1.1/20/A/046
1.1.1.1/20/A/047
1.1.1.1/20/A/048
Usage of conservative borrelia protein as vaccine target
1.1.1.1/20/A/124
1.1.1.1/20/A/126
Fifth selection round projects
1.1.1.1/21/A/029
1.1.1.1/21/A/033
1.1.1.1/21/A/044
1.1.1.1/21/A/050
Large area deposition technologies of multifunctional antibacterial and antiviral nanocoatings
1.1.1.1/21/A/079
AI-improved organ on chip cultivation for personalised medicine (AImOOC)
1.1.1.2. Activity Post-doctoral Research Aid
First selection round projects
1.1.1.2/VIAA/1/16/203
Engineering of extracellular vesicles to transfer tumor suppressor miRNA to cancer cells
1.1.1.2/VIAA/1/16/144
Structural and functional studies of Lyme disease agent Borrelia burgdorferi outer surface proteins to reveal the mechanisms of pathogenesis with the intention to create a new vaccine
1.1.1.2/VIAA/1/16/135
sRNAflow – a tool for analysis of small RNA-seq data
1.1.1.2/VIAA/1/16/128
Investigation of interaction of smoked dietary products with gut microbiome
Second selection round projects
1.1.1.2/VIAA/2/18/286
1.1.1.2/VIAA/2/18/285
1.1.1.2/VIAA/2/18/287
Third selection round projects
1.1.1.2/VIAA/3/19/463
1.1.1.2/VIAA/3/19/464
Structural and kinetic studies of human carbonic anhydrases as multiple drug targets
1.1.1.2/VIAA/3/19/462
Structural and functional studies of Ryegrass mottle virus-encoded proteins
1.1.1.2/VIAA/3/19/460
Fourth selection round projects
1.1.1.2/VIAA/4/20/704
Structural studies of a Borrelia burgdorferi bacteriophage
1.1.1.2/VIAA/4/20/705
1.1.1.2/VIAA/4/20/728
1.1.1.4 Development of the R&D Infrastructure in Fields of Smart Specialisation and Strengthening of Institutional Capacity of Scientific Institutions
1.1.1.1/20/A/ 045
Development of a novel microfluidic device for label-free quantification of prostate cancer-derived extracellular vesicles and analysis of their RNA content (PROCEX)
1.1.1.5. Support for International Cooperation Projects in Research and Innovation
1.1.1.5/18/I/006
Support for the integration of the Latvian Biomedical Research and Study Centre into the European Research Area and Infrastructure objects
1.1.1.5/20/A/002
European resercher Night in Latvia 2020
1.2.1. Specific Aid Objective To increase private sector investment in R&D
1.2.1.2. Activity Support for Improvement of Technology Transfer System
KC-PI-2017/23
Precision medicine test for the therapeutic decisions and monitoring of treatment response in breast cancer
KC-PI-2017/83
Plant virus-derived vaccine technology platform
KC-PI-2017/84
Development of anti-Lyme disease vaccine candidate
KC-PI-2020/23
Development of anti-myostatin vaccine for promotion of livestock animal muscle growth
European Social Fund (ESF)
8.2.2. Strengthen academic staff of higher education institutions in areas of strategic specialisation. Third selection round.
8.2.2.0/20/I/006
Strengthening LU doctoral capacity under the new doctoral model